Nathan J Verlinden

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Therapeutics and clinical risk management

ASAIO journal (American Society for Artificial Internal Organs : 1992)

Artificial organs

Allegheny General Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Allegheny General Hospital

United States

Clinical Pharmacy Specialist - Cardiology :: Pharmacy

Publications

Margaret M Buck, Chelsea I Barry, Courtney A Montepara, Nathan J Verlinden
Platelet Function Testing to Guide Cangrelor Dosing in Patients with Temporary Mechanical Circulatory Support or as a Bridge to Procedure. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Margaret M Buck, Chelsea I Barry, Courtney A Montepara, Nathan J Verlinden
Platelet Function Testing to Guide Cangrelor Dosing in Patients with Temporary Mechanical Circulatory Support or as a Bridge to Procedure. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Margaret M Buck, Chelsea I Barry, Courtney A Montepara, Nathan J Verlinden
Platelet Function Testing to Guide Cangrelor Dosing in Patients with Temporary Mechanical Circulatory Support or as a Bridge to Procedure. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Dana Cohan, Marissa N Uricchio, Chelsea I Konopka, Courtney A Montepara, Nathan J Verlinden
Comparison of clinical outcomes with cangrelor plus aspirin versus oral dual antiplatelet therapy in patients supported with venoarterial extracorporeal membrane oxygenation. Artificial organs (2023)
Mareena Shuster, Chelsea I Konopka, Nathan J Verlinden
Incidence and Timing of Thrombocytopenia in Patients Receiving Impella Ventricular Assist Device Support. ASAIO journal (American Society for Artificial Internal Organs : 1992) 68 (9) (2022)
Hayah Kassis-George, Nathan J Verlinden, Sheng Fu, Manreet Kanwar
Vericiguat in Heart Failure with a Reduced Ejection Fraction: Patient Selection and Special Considerations. Therapeutics and clinical risk management 18 (2022)
Nathan J Verlinden, Claire Walter, Amresh Raina, Raymond L Benza
A Case Report of a Patient With Pulmonary Arterial Hypertension Transitioned From Inhaled Iloprost to Selexipag. Journal of pharmacy practice 34 (6) (2020)
Nathan J Verlinden, Raymond L Benza, Amresh Raina
Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension. Pulmonary circulation 10 (4) (2020)
Nathan J Verlinden, Claire Walter, Manreet Kanwar, Amresh Raina
Transition From Oral Treprostinil to Selexipag in a Patient With Pulmonary Arterial Hypertension. The Annals of pharmacotherapy 53 (7) (2019)

Nathan J Verlinden.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nathan J Verlinden